Form 10-K for the Fiscal Year ended December 31, 2024
We note that you provide a table on page 104 that is prefaced with language indicating it reflects activity in both restricted common shares and restricted stock units, although the summations indicate the balances represent nonvested shares.Rest of the question
We also note the activity includes grants, adjusted to exclude forfeitures of stock units, which you indicate are related to performance targets or service requirements that were not achieved, and are adjusted to exclude vested awards. Please modify your disclosures to clarify how this activity relates to the activity in your Statements of Changes in Equity on page 73 that is labeled "Forfeitures of vested restricted stock awards and exercised stock options" and if such activity has been properly identified, to describe the circumstances under which vested awards were forfeited. Please also revise the headers to the tables in this section where necessary to correspond precisely with the type of securities or instruments being measured. Please disaggregate activity pertaining to different types of securities or instruments that are presently combined in the summary tables, or expand your disclosures to discuss your rationale and views on the utility of the combined presentation.
The Company acknowledges the Staff’s comment and will revise its disclosure to caption its table as “Share-based Compensation Awards Outstanding,” rather than “Nonvested SharesRead in the reply
Outstanding” in future annual filings.
In addition, the Company will revise the line in the Statements of
Changes in Equity labeled "Forfeitures of vested restricted stock awards and exercised stock options" to “Common stock withheld related to net share settlement of equity awards,” which further identifies the nature of the activity that is included in this line, in future quarterly and annual filings, commencingRest of the answer
with the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2025.
The difference between (i) the estimated value of the common stock withheld from employees for the net share settlement of equity awards as disclosed on page 102 (derived by multiplying the number of shares withheld/repurchased of 158,591, 147,294 and 513,479 by the average costs of $53.42, $44.09 and $41.79 per share, respectively), and (ii) the amounts disclosed in the "Forfeitures of vested restricted stock awards and exercised stock options" lines of the Statements of Changes in Equity on page 73, represents the dollar value of the common shares withheld from employees to cover the exercise cost of their stock options. As the common shares issued at the exercise of the stock options were simultaneously cancelled to cover the exercise cost of said options, the net impact is appropriately zero in the Statements of Changes in Equity.
(Dollars in Thousands)
Common stock withheld related to net share settlement of equity awards per page 73
$ 7,055
$ 5,819
$ 6,097
Common stock withheld related to net share settlement of equity awards per page 102
8,472
6,494
21,459
$ (1,417 )
$ (675 )
$ (15,362 )
The Company will also disaggregate activity pertaining to the different types of share-based compensation awards in future annual reports commencing with the Company’s Annual Report on Form 10-K for the year ended December 31, 2025, as follows:
Activity for the three years ended December 31,
Total
Restricted Common
Stock
Time-based Restricted
Stock Units
Performance-based
Restricted Stock Units
Stock Options
Share-based Compensation Awards Outstanding at
December 31, 2021
1,147,947
87,721
125,119
123,201
811,906
Grants
515,154
348,846
124,590
PRSU Adjustments for above target achievement
16,092
PRSU Cancellations for below target achievement
Forfeitures options exercised(1)
(541,656 ) shares, RSUs and PRSUs Vested ($16.6 - $23.53 per share)(1)
(216,889 )
(80,138 )
(62,401 )
(74,350 )
Share-based Compensation Awards Outstanding at December 31, 2022
920,648
49,301
411,564
189,533
270,250
132,658
52,890
16,233
(3,641 )
(30,654 )
Shares, RSUs and PRSUs Vested ($19.63 - $43.05 per share)(1)
(311,004 )
(46,660 )
(186,809 )
(77,535 ) at December 31, 2023
724,240
29,519
277,645
177,480
239,596
151,974
82,076
48,080
31,144
(65,179 )
Shares, RSUs and PRSUs Vested ($19.63 - $57.17 per share)(1)
(330,186 )
(33,629 )
(140,823 )
(155,734 ) at December 31, 2024
511,993
17,708
218,898
100,970
174,417
(1) Includes 158,591 (2024), 147,294 (2023), and 513,479 (2022) shares of common stock withheld to cover employee withholding taxes and the cost of options exercised in connection with the net settlement of restricted stock units and the exercise of stock options.
The following is a reconciliation of the total of the stock options exercised and RSUs and PRSUs vested lines in the table above to the Common stock issued - vesting or exercise of share-based compensation line in the roll forward of outstanding shares on page 2 of this letter:
First report after the company's reply of Jul 31, 2025: 10-Q filed Aug 6, 2025 ↗, against the 10-Q filed May 8, 2025 ↗.
Tickdelta does not hold the text of both reports, so they are not compared here.
Also in this review: request for more time, Jul 23, 2025, closing letter, 2025-08-25